• 3/28/2022

    Doha 27 March, 2022: More than 800 healthcare professionals virtually attended the Sixth Qatar Diabetes, Endocrinology, and Metabolic Conference (QDEM-6) which was hosted by Hamad Medical Corporation’s (HMC) Endocrine and Diabetes Division, Department of Medicine, and the Qatar Metabolic Institute (QMI).
    The conference, held virtually with attendees and speakers from around the world, brought together local and international experts in the fields of endocrinology, obesity, and diabetes to discuss the latest research, treatments, technological advances, and preventative measures for these conditions.

    Dr. Mahmoud Ali Zirie, Chair of the Conference’s Organizing Committee and Head of HMC’s Endocrinology and Diabetes Division, said the conference provided an opportunity to share the work being done here in Qatar and to deliver improvements tailored to the local population. technology in diabetes management.
    Professor Abdul Badi Abou Samra, Director of Qatar Metabolic Institute, said the virtual event provided an important platform for frontline clinicians, scientists, and researchers to discuss strategies and approaches for the management and prevention of diabetes and associated conditions.

    “Diabetes is a complex condition which can lead to debilitating long-term complications and acute illness. The disease in Qatar is quite prevalent with about 17 percent of Qatar’s adult population thought to have diabetes. About 20 percent of Qatar’s population is estimated to be pre-diabetic,” he said.

    Dr. Ibrahim Al Janahi, Chair of the Scientific Committee and Senior Consultant in Endocrine and Diabetes Division said many diabetics live with other associated complications such as high blood pressure, kidney disease, and vision impairment. 
    “It is important for the local and international medical community to meet and discuss trends, best practice, and long-term strategies for the prevention and mitigation of complications related to this disease so we can continue to provide the best care for our patients,” Dr. Al Janahi said.

    Speakers at this year’s event included Professor Ewan Pearson, Head of Division, Population Health & Genomics, School of Medicine, University of Dundee, UK; Professor Richard J. Auchus, MD, PhD who is Professor of Translational Medicine in the Departments of Pharmacology and Internal Medicine at the University of Michigan; and Dr. Seema Kumar is Professor of Pediatrics in the Department of Pediatric and Adolescent Medicine at Mayo Clinic.

    “This year our program focused on a range of important and emerging areas including diabetes and obesity in young people, the latest in diabetes technology, adrenal disorders and reversal of diabetes,” Dr. Zirie said. 

    “As we continue to live with COVID-19, it’s more important than ever that healthcare professionals have access to the most up-to-date research and information about diabetes, endocrinology and metabolic medicine.”